Novo Japan Notches 10% Growth in 2020, President Proud of This Feat amid Market Decline

April 13, 2021
Novo Nordisk Japan President Ole Moelskov Bech Novo Nordisk saw its sales climb 10.4% to 97.8 billion yen in Japan in 2020, becoming one of a small number of pharma companies to rack up growth in the falling market, with...read more